Package leaflet: Information for the patient. Oxycodone Orion 10 mg/ml solution for injection/infusion. Oxycodone hydrochloride
|
|
- Gerard Nash
- 5 years ago
- Views:
Transcription
1 Package leaflet: Information for the patient Oxycodone Orion 10 mg/ml solution for injection/infusion Oxycodone hydrochloride Read all of this leaflet carefully before you are given this medicine because it contains important information for you. - Keep this leaflet. You may need to read it again. - If you have any further questions, ask your doctor or nurse. - This medicine has been prescribed for you only. Do not pass it on to others. It may harm them, even if their signs of illness are the same as yours. - If you get any side effects, talk to your doctor or nurse. This includes any possible side effects not listed in this leaflet. See section 4. What is in this leaflet 1. What Oxycodone Orion is and what it is used for 2. What you need to know before you are given Oxycodone Orion 3. How to use Oxycodone Orion 4. Possible side effects 5. How to store Oxycodone Orion 6. Contents of the pack and other information 1. What Oxycodone Orion is and what it is used for This solution for injection/infusion contains the active ingredient oxycodone, which belongs to a group of medicines called opioids. This medicinal product is prescribed for you by your doctor to relieve severe pain which can be adequately managed only with opioid analgesics. 2. What you need to know before you are given Oxycodone Orion Do not use Oxycodone Orion - if you are allergic to oxycodone or any of the other ingredients of this medicine (listed in section 6) - if you have severe breathing problems - if you have problems with clearing the mucus from your airways - if you have convulsions - if you have coma - if you have acute abdominal pain - if you have severe liver impairment - if you have previously suffered anxiety during influence of alcohol or sedatives - if you have a type of bowel obstruction called paralytic ileus - if you have too high blood carbon dioxide concentration - if you have a disease affecting both heart and lungs called cor pulmonale - if you have severe chronic asthma or severe chronic obstructive lung disease. Warnings and precautions Talk to your doctor before you are given Oxycodone Orion - if you have severely impaired lung function 1
2 - if you have myxedema (illnesses of the thyroid gland with symtoms like dry, waxy swelling of the skin, low metabolism) - impaired function of the thyroid gland - if you have adrenal insufficiency for example Addison s disease - if you have psychosis caused by toxic substances - if you have enlarged prostate (prostatic hypertrophy) - if you are or have ever been addicted to alcohol or drugs - if you have delirium tremens due to alcohol withdrawal - if you have head injury - if you have low blood pressure - if you have decreased blood volume - if you have problems in kidney or liver - if you have inflammatory bowel disorders - if you have a disease of the biliary tract - if you have spasms in gallbladder or urinary tract - if you have inflammation of the pancreas - if you use monoamine oxidase (MAO) inhibitors (used to treat depression or Parkinson s disease) - if you are older and debilitated - if you have recently undergone any surgery or if a surgery is planned in the next few days. Tell your doctor during treatment - when your bowels does not work properly. This may indicate intestinal obstruction and then the treatment should be stopped immediately. - if your pain is not relieved even if the oxycodone dose is increased. Long-term use Use of Oxycodone Orion over long periods can cause physical dependence. Therefore, the dose should be reduced gradually when treatment is stopped (see section 3, If your treatment with Oxycodone Orion is stopped ). Children There is not enough information to recommend the use of Oxycodone Orion to children. Other medicines and Oxycodone Orion Tell your doctor if you are using, have recently used or might use any other medicines, including medicines obtained without a prescription. If you use Oxycodone Orion with some other medicines, the effect of this injection/infusion or the other medicines may be changed. Tell your doctor or pharmacist if you are taking - medicines to help you sleep or to treat anxiety (tranquillisers, hypnotics or sedatives) - medicines to treat depression - medicines to treat psychiatric or mental disorders (such as phenothiazines or neuroleptics) - other strong analgesics (for instance other opioids) - medicines to relieve allergic reactions (antihistamines) - medicines to relieve nausea or vomiting (antiemetics) - medicines to treat Parkinson s disease - cimetidine, which is used to treat heartburn or peptic ulcer - medicines to stop blood from clotting (warfarin) - macrolide antibiotics - medicines to treat fungal infections - medicines to treat HIV/AIDS - medicines to treat tuberculosis - medicines to treat epilepsy - medicines to treat heart arrhythmia - St. John s Wort 2
3 - or if you have taken a monoamine oxidase (MAO) inhibitor during the last two weeks. MAO inhibitors are used to treat depression or Parkinson s disease. Concomitant use of Oxycodone Orion and sedative medicines such as benzodiazepines or related drugs increases the risk of drowsiness, difficulties in breathing (respiratory depression), coma and may be life-threatening. Because of this, concomitant use should only be considered when other treatment options are not possible. However if your doctor does prescribe Oxycodone Orion together with sedative medicines the dose and duration of concomitant treatment should be limited by your doctor. Please tell your doctor about all sedative medicines you are taking, and follow your doctor s dose recommendation closely. It could be helpful to inform friends or relatives to be aware of the signs and symptoms stated above. Contact your doctor when experiencing such symptoms. Oxycodone Orion with food, drink and alcohol Oxycodone Orion solution for injection/infusion can be used with food and drink. However, avoid grapefruit juice as it can affect oxycodone plasma levels. Alcohol Do not drink alcohol during treatment. Alcohol can enhance some dangerous side effects of oxycodone, such as severe breathing problems, when used during treatment. Pregnancy and breast-feeding If you are pregnant or breast-feeding, think you may be pregnant or are planning to have a baby, ask your doctor or pharmacist for advice before taking this medicine. The use of Oxycodone Orion should be avoided to the extent possible during pregnancy and breastfeeding. Pregnancy There are limited data from the use of oxycodone in pregnant women. Oxycodone crosses the placenta into the blood circulation of the baby. Use of oxycodone during pregnancy may cause withdrawal symptoms in the newborn. Infants born to mothers who have recieved oxycodone during the last 3-4 weeks before labour can cause severe breathing difficulties in the newborn. Oxycodone Orion should only be used during pregnancy if the benefit outweighs the possible risks to the baby. Breast-feeding Oxycodone may pass into breast milk and may cause breathing difficulties in the newborn. Oxycodone Orion should therefore not be used during breast-feeding. Driving and using machines This medicinal product may impair your reaction and cause side effects such as dizziness and sleepiness which could effect your ability to drive or use machines. These are usually most noticeable when you first start using Oxycodone Orion, or when changing to a higher dose. Do not drive or use any tools or machines if you are affected. Oxycodone Orion contains sodium This medicine contains less than 1 mmol sodium (23 mg) per dose, that is to say essentially sodiumfree. 3
4 3. How to use Oxycodone Orion Your doctor prescribes the dose individually to you according to your age, the severity of your pain, the general condition, possible concomitant diseases, and your previous and concomitant medication. A healthcare professional will prepare and give this medicinal product to you either as an injection (under the skin, into a vein or into a muscle) or as a drip (under the skin or into a vein). You will be given Oxycodone Orion for as short a period of time as possible. Instructions for use for medical or healthcare professionals are provided at the end of this leaflet. If you are given more Oxycodone Orion than you should Oxycodone Orion is given to you by healthcare professionals. An overdose is therefore unlikely. If you have received more medicine than you should have, contact your doctor or hospital immediately. The symptoms for overdose are small pupils, severe breathing problems, sleepiness, skeletal muscle flaccidity, slow heart rate and too low blood pressure. In severe cases even coma and death may occur. When seeking medical attention take this leaflet and any remaining solution for injection or infusion with you and show to the doctor. If your treatment with Oxycodone Orion is stopped You should not suddenly stop using this medicine unless your doctor tells you to. If you want to stop using your injection, discuss this with your doctor first. The dose is usually reduced gradually, so that you do not experience unpleasant effects. Abrupt withdrawal of treatment can cause withdrawal symptoms such as restlessness, runny eyes and nose, sweats and broken sleep within 24 hours. If you have any further questions on the use of this product, ask your doctor or nurse. 4. Possible side effects Like all medicines, this medicine can cause side effects, although not everybody gets them. This medicine can in some uncommon cases cause severe side effects. Stop taking Oxycodone Orion and contact your doctor immediately if following symptoms occur: - Depressed breathing, which is most likely to occur in elderly or debilitated patients. This medicine can also cause bronchial spasms, difficulty in breathing and suppress the cough reflex. - dizziness which can be a symptom of severe drop in blood pressure - constricted pupils which can be a symptom of overdosing - gallstone attack - life-threatening allergic reaction (anafylactoid and anaphylactic reactions). Oxycodone can also cause following side effects: Very common (may affect more than 1 in 10 people): - dizziness, sleepiness, headache - constipation, nausea, vomiting. Your doctor can prescribe appropriate medicines to treat these symptoms. - itching. Common (may affect up to 1 in 10 people): - anxiety, confusional state, nervousness, depression, abnormal thinking, insomnia - tremor - a fall in blood pressure on standing up which causes dizziness, light-headedness or fainting - difficulties in breathing 4
5 - abdominal pain, loss of appetite, diarrhoea, problems with digestion, dry mouth - rash, excessive sweating - fluid retention, faintness, sweating, chills, lack or loss of strength and energy. Uncommon (may affect up to 1 in 100 people): - agitation, hallucinations, amnesia, emotional lability, euphoria - convulsions, involuntary muscle contractions, excessive muscle tension, reduced sence of touch, sensation of numbness or tingling of the skin, speech disorder, fainting, vertigo - widening of blood vessels - change in sense of taste, gastrointestinal disorder, flatulence, difficulty in swallowing, intestinal obstruction, belching - increased liver enzyme values - urticaria, dryness of the skin - difficulty in passing urine, urethral spasm - absence of menstruation, decreased libido, impotence - swelling of extremities, thirst, drug withdrawal syndrome, malaise, drug tolerance - hypersensitivity - dehydration - drug dependence - visual impairment - palpitations (in connection with oxycodone withdrawal). Rare (may affect up to 1 in 1,000 people): - allergic reaction, severe hypersensitivity reactions. Not known (frequency cannot be estimated from the available data): - aggression - abnormally increased pain sense - dental caries - stoppage or suppression of the flow of bile. Reporting of side effects If you get any side effects, talk to your doctor or pharmacist. This includes any possible side effects not listed in this leaflet. You can also report side effects directly via the national reporting system listed in Appendix V. By reporting side effects you can help provide more information on the safety of this medicine. 5. How to store Oxycodone Orion Keep this medicine out of the sight and reach of children. Do not use this medicine after the expiry date which is stated on the label and carton after EXP. The expiry date refers to the last day of that month. This medicine does not require any special temperature storage conditions. Store in the original package in order to protect from light. Once the ampoule is opened the solution for injection/infusion should be used immediately. Any unused portion should be discarded. Do not throw away any medicines via wastewater or household waste. Ask your pharmacist how to throw away medicines you no longer use. These measures will help to protect the environment. 5
6 6. Contents of the pack and other information What Oxycodone Orion contains - The active substance is oxycodone hydrochloride. Each ml contains 10 mg of oxycodone hydrochloride. - The other ingredients are citric acid monohydrate, sodium citrate, sodium chloride, hydrochloric acid (for ph adjustment), sodium hydroxide (for ph adjustment), water for injections. What Oxycodone Orion looks like and contents of the pack Oxycodone Orion solution for injection/infusion is a clear, colourless solution. It is supplied in glass ampoules packed in cardboard boxes including 5 x 1 ml, 5 x 2 ml or 5 x 10 ml. 1 ml filling volume in 2 ml glass ampoules with two yellow colour rings, 2 ml ampoules with two colour rings: upper ring is brown and lower ring is yellow and 10 ml ampoules with two colour rings: upper ring is dark blue and lower ring is yellow. Not all pack sizes may be marketed. Marketing Authorisation Holder and Manufacturer Marketing Authorisation Holder Orion Corporation Orionintie 1 FI Espoo Finland Manufacturer Orion Corporation Orion Pharma Orionintie 1 FI Espoo Finland This medicinal product is authorised in the Member States of the EEA under the following names: Denmark: Oxycodone Orion 10 mg/ml injektions- og infusionsvæske, opløsning Finland: Oxycodone Orion 10 mg/ml injektio- / infuusioneste, liuos Sweden: Oxycodone Orion 10 mg/ml injektions-/infusionsvätska, lösning This leaflet was last revised in <[To be completed nationally]> Detailed information on this medicine is available on the website of {MS/Agency} 6
7 The following information is intended for healthcare professionals only. See SmPC for more information. These instructions provide technical information about Oxycodone Orion 10 mg/ml solution for injection/infusion. Instructions for use/handling Use solution for injection/infusion immediately after opening. Any unused portion should be discarded. If needed, dilute with 9 mg/ml (0.9%) saline or 50 mg/ml (5%) glucose or water for injections. If Oxycodone Orion injection/infusion is used concurrently with cyclizine, mixed solution is diluted with water for injections. 9 mg/ml (0.9%) sodium chloride solution must not be used. If the concentration of cyclizine in the mixed combination is under 3 mg/ml, mixture is physically and chemically stable for 24 hours at room temperature. If the concentration of cyclizine in the mixture is over 3 mg/ml, solution is unstable and may be precipitated. Prochlorperazine is chemically incompatible with Oxycodone Orion injection/infusion. Oxycodone Orion injection/infusion, undiluted or diluted to 9 mg/ml (0.9%) sodium chloride solution, 50 mg/ml (5%) glucose solution or water for injections is physically and chemically stable when in contact with polypropylene or polycarbonate syringes, polyethylene or PVC tubing and PVC, EVA, polyolefin / polyamide, low density polyethylene and polypropylene infusion bags, over 24 hours at room temperature. The injection/infusion, whether undiluted or diluted, does not need to be protected from light, if it is used with the solution for infusion and equipment combinations used in these studies. Inappropriate handling of the undiluted solution after opening of the original ampoule, or of the diluted solutions may compromise the sterility of the product. Any unused medicinal product or waste material should be disposed of in accordance with local requirements. 7
Package leaflet: Information for the user. Morfin Abcur 10 mg/ml, solution for injection. morphine hydrochloride
Package leaflet: Information for the user Morfin Abcur 10 mg/ml, solution for injection morphine hydrochloride Read all of this leaflet carefully before you start using this medicine because it contains
More informationPackage leaflet: Information for the user
Package leaflet: Information for the user Lidocaine Accord 10 mg/ml solution for injection Lidocaine Accord 20 mg/ml solution for injection Lidocaine hydrochloride Read all of this leaflet carefully before
More informationPackage leaflet: Information for the patient. Lindoxa 10 mg/ml solution for injection/infusion. oxycodone hydrochloride
Package leaflet: Information for the patient Lindoxa 10 mg/ml solution for injection/infusion oxycodone hydrochloride Read all of this leaflet carefully before you start taking this medicine because it
More informationPackage leaflet: Information for the patient. Morphine Unimedic 1 mg/ml solution for injection morphine hydrochloride trihydrate
Package leaflet: Information for the patient Morphine Unimedic 1 mg/ml solution for injection morphine hydrochloride trihydrate Read all of this leaflet carefully before you start using this medicine because
More informationTEMGESIC Injection Buprenorphine (as hydrochloride)
TEMGESIC Injection Buprenorphine (as hydrochloride) Consumer Medicine Information What is in this leaflet This leaflet answers some common questions about TEMGESIC. It does not contain all the available
More informationPackage leaflet: Information for the patient. Chlorphenamine 10 mg/ml Solution for Injection (Chlorphenamine Maleate)
Package leaflet: Information for the patient Chlorphenamine 10 mg/ml Solution for Injection (Chlorphenamine Maleate) Read all of this leaflet carefully before you start taking this medicine because it
More informationPACKAGE LEAFLET: INFORMATION FOR THE USER. Meptid 100 mg/ml Solution for Injection. Meptazinol
PACKAGE LEAFLET: INFORMATION FOR THE USER Meptid 100 mg/ml Solution for Injection Meptazinol Read all of this leaflet carefully before you start taking this medicine. - Keep this leaflet. You may need
More informationMEDICATION GUIDE Oxycodone Hydrochloride (ox-ee-co-dohn) (CII) Oral Solution, USP
MEDICATION GUIDE Oxycodone Hydrochloride (ox-ee-co-dohn) (CII) Oral Solution, USP IMPORTANT: Keep oxycodone hydrochloride oral solution in a safe place away from children. Accidental use by a child is
More informationCORE SAFETY PROFILE OXYCODONE HYDROCHLORIDE NL/H/PSUR/0054/ January 2013
CORE SAFETY PROFILE OXYCODONE HYDROCHLORIDE NL/H/PSUR/0054/001 16 January 2013 1 4.2 Posology and method of administration (safety aspects only) Posology Elderly patients For oral preparations A dose adjustment
More informationPackage leaflet: Information for the user. Exembol 1 mg/ml solution for infusion. argatroban monohydrate
Package leaflet: Information for the user Exembol 1 mg/ml solution for infusion argatroban monohydrate Read all of this leaflet carefully before you start using this medicine because it contains important
More informationPackage leaflet: Information for the user. Midazolam 2 mg/ml Solution for Injection or Infusion Midazolam 5 mg/ml Solution for Injection or Infusion
Package leaflet: Information for the user Midazolam 2 mg/ml Solution for Injection or Infusion Midazolam 5 mg/ml Solution for Injection or Infusion Midazolam (as Midazolam hydrochloride) Read all of this
More informationPackage leaflet: Information for the user. Tobramycin 40 mg/ml Solution for Injection tobramycin
Package leaflet: Information for the user Tobramycin 40 mg/ml Solution for Injection tobramycin Read all of this leaflet carefully before you start using this medicine because it contains important information
More informationPATIENT INFORMATION LEAFLET. MIDORYX (MIDAZOLAM INJECTION 5mg, 10mg BP)
PATIENT INFORMATION LEAFLET MIDORYX (MIDAZOLAM INJECTION 5mg, 10mg BP) Read all of this leaflet carefully before you start using this medicine. Keep this leaflet. You may need to read it again. If you
More informationMEDICATION GUIDE Morphine Sulfate (MOR feen SUL fate) (CII) Oral Solution
MEDICATION GUIDE Morphine Sulfate (MOR feen SUL fate) (CII) Oral Solution IMPORTANT: Keep morphine sulfate oral solution in a safe place away from children. Accidental use by a child is a medical emergency
More informationPackage leaflet: Information for the user. Co-Codamol 30mg/500mg Capsules (Codeine Phosphate Hemihydrate and Paracetamol)
Package leaflet: Information for the user Co-Codamol 30mg/500mg Capsules (Codeine Phosphate Hemihydrate and Paracetamol) Read all of this leaflet carefully before you start taking this medicine because
More informationPackage leaflet: Information for the user. Cyclizine Lactate 50 mg/ml Injection
Package leaflet: Information for the user Cyclizine Lactate 50 mg/ml Injection Read all of this leaflet carefully before you start taking this medicine because it contains important information for you.
More informationPackage leaflet: Information for the patient Tranexamic acid 100 mg/ml Solution for Injection tranexamic acid
Package leaflet: Information for the patient Tranexamic acid 100 mg/ml Solution for Injection tranexamic acid Read all of this leaflet carefully before you are given this medicine because it contains important
More informationTREANA 5mg and 10mg Film-coated Tablets
PACKAGE LEAFLET: INFORMATION FOR THE USER TREANA 5mg and 10mg Film-coated Tablets OLANZAPINE This leaflet is a copy of the Summary of Product Characteristics and Patient Information Leaflet for a medicine,
More informationPACKAGE LEAFLET: INFORMATION FOR THE USER. Meptid 100 mg/ml Solution for Injection. Meptazinol Hydrochloride
PACKAGE LEAFLET: INFORMATION FOR THE USER Meptid 100 mg/ml Solution for Injection Meptazinol Hydrochloride Read all of this leaflet carefully before you start taking this medicine. - Keep this leaflet.
More informationPackage leaflet: Information for the user. Novastan 100 mg/ml concentrate for solution for infusion. argatroban monohydrate
Package leaflet: Information for the user 100 mg/ml concentrate for solution for infusion argatroban monohydrate Read all of this leaflet carefully before you start using this medicine because it contains
More informationPACKAGE LEAFLET: INFORMATION FOR THE USER. Dopamine 40 mg/ml Sterile Concentrate
PACKAGE LEAFLET: INFORMATION FOR THE USER Dopamine 40 mg/ml Sterile Concentrate Read all of this leaflet carefully before you start using this medicine. Keep this leaflet. You may need to read it again.
More informationPackage leaflet: Information for the user. Ebateva 20 mg Orodispersible Tablets. Ebastine
Package leaflet: Information for the user Ebateva 10 mg Orodispersible Tablets Ebateva 20 mg Orodispersible Tablets Ebastine Read all of this leaflet carefully before you start taking this medicine because
More informationPackage leaflet: Information for the patient. Vertigon 8 mg Tablets Vertigon 16 mg Tablets (betahistine dihydrochloride)
Package leaflet: Information for the patient Vertigon 8 mg Tablets Vertigon 16 mg Tablets (betahistine dihydrochloride) Read all of this leaflet carefully before you start taking this medicine because
More informationXYZAL 5 MG FILM-COATED TABLET
XYZAL 5 MG FILM-COATED TABLET Levocetirizine dihydrochloride Read all of this leaflet carefully because it contains important information for you. This medicine is available without prescription. However,
More informationMEDICATION GUIDE MORPHINE Sulfate Oral Solution (mor-pheen) CII Rx only
MEDICATION GUIDE MORPHINE Sulfate Oral Solution (mor-pheen) CII Rx only IMPORTANT: Keep Morphine Sulfate Oral Solution in a safe place away from children. Accidental use by a child is a medical emergency
More informationRABEPRAZOL 10mg and 20mg Gastro-resistant Tablets
PACKAGE LEAFLET: INFORMATION FOR THE USER RABEPRAZOL 10mg and 20mg Gastro-resistant Tablets RABEPRAZOLE This leaflet is a copy of the Summary of Product Characteristics and Patient Information Leaflet
More informationPackage leaflet: Information for the user. Lidocaine Hydrochloride 1% w/v Solution for Injection Lidocaine Hydrochloride
Package leaflet: Information for the user Lidocaine Hydrochloride 1% w/v Solution for Injection Lidocaine Hydrochloride Read all of this leaflet carefully before you start using this medicine because it
More informationPACKAGE LEAFLET: INFORMATION FOR THE USER
PACKAGE LEAFLET: INFORMATION FOR THE USER 250 mg film-coated tablets. 500 mg film-coated tablets. 750 mg film-coated tablets. 1000 mg film-coated tablets. Levetiracetam
More informationPACKAGE LEAFLET: INFORMATION FOR THE USER. Dantrium 25 mg Capsules / Dantrium 100 mg Capsules Dantrolene sodium
PACKAGE LEAFLET: INFORMATION FOR THE USER Dantrium 25 mg Capsules / Dantrium 100 mg Capsules Dantrolene sodium Read all of this leaflet carefully before you start taking this medicine because it contains
More informationPACKAGE LEAFLET: INFORMATION FOR THE USER. DF118 Tablets 30mg (Dihydrocodeine Hydrogen Tartrate)
PACKAGE LEAFLET: INFORMATION FOR THE USER DF118 Tablets 30mg (Dihydrocodeine Hydrogen Tartrate) Read all of this leaflet carefully before you start taking this medicine. - Keep this leaflet. You may need
More informationPackage leaflet: Information for the patient. Brimonidine Biogaran 2 mg/ml eye drops, solution. brimonidine tartrate
Package leaflet: Information for the patient Brimonidine Biogaran 2 mg/ml eye drops, solution brimonidine tartrate Read all of this leaflet carefully before you start using this medicine because it contains
More information2. What you need to know before you use OxyNorm injection
Package leaflet: Information for the user OxyNorm 50 mg/ml, solution for injection or infusion Oxycodone hydrochloride Read all of this leaflet carefully before you start using this medicine because it
More informationPackage leaflet: Information for the user. Cefixime ABR 100 mg/5 ml powder for oral suspension Cefixime
Package leaflet: Information for the user Cefixime ABR 100 mg/5 ml powder for oral suspension Cefixime Read all of this leaflet carefully before you start taking this medicine because it contains important
More informationPACKAGE LEAFLET: INFORMATION FOR THE USER. Calcium Folinate 10 mg/ml Injection
PACKAGE LEAFLET: INFORMATION FOR THE USER Calcium Folinate 10 mg/ml Injection Read all of this leaflet carefully before you start using this medicine. Keep this leaflet. You may need to read it again.
More informationPackage Leaflet: INFORMATION FOR THE USER. PARACODIN 10 mg/g oral drops, solution (dihydrocodeine hydrorhodanide)
Package Leaflet: INFORMATION FOR THE USER PARACODIN 10 mg/g oral drops, solution (dihydrocodeine hydrorhodanide) Read all of this leaflet carefully before you start taking this medicine because it contains
More informationVentolin Injection 500 micrograms/ml salbutamol sulfate
Package leaflet: Information for the user Ventolin Injection 500 micrograms/ml salbutamol sulfate Read all of this leaflet carefully before you start taking this medicine because it contains important
More informationPackage leaflet: Information for the user Efedrin Stragen 3mg/ml, solution for injection Ephedrine hydrochloride
Package leaflet: Information for the user Efedrin Stragen 3mg/ml, solution for injection Ephedrine hydrochloride Read all of this leaflet carefully before you start using this medicine because it contains
More informationShare the important information in this Medication Guide with members of your household.
Medication Guide BUPRENORPHINE (BUE-pre-NOR-feen) and NALOXONE (nal-ox-one) Sublingual Tablets, CIII IMPORTANT: Keep buprenorphine and naloxone sublingual tablets in a secure place away from children.
More informationPackage leaflet: Information for the patient. / / 30 mg/5 ml syrup. Ambroxol hydrochloride
Package leaflet: Information for the patient / / 30 mg/5 ml syrup Ambroxol hydrochloride Read all of this leaflet carefully before you start taking this medicine because it contains important information
More informationPackage leaflet: Information for the patient. NEGABAN 1g, powder for solution for injection or infusion Temocillin
Package leaflet: Information for the patient NEGABAN 1g, powder for solution for injection or infusion Temocillin Read all of this leaflet carefully before you start using this medicine because it contains
More informationPackage leaflet: Information for the patient. Tranexamic Acid 100 mg/ml, Solution for Injection tranexamic acid
Package leaflet: Information for the patient Tranexamic Acid 100 mg/ml, Solution for Injection tranexamic acid Read all of this leaflet carefully before you are given this medicine because it contains
More informationPackage leaflet: Information for the user Glycopyrronium Bromide 200 micrograms/ml injection (Glycopyrronium Bromide)
Package leaflet: Information for the user Glycopyrronium Bromide 200 micrograms/ml injection (Glycopyrronium Bromide) Read all of this leaflet carefully before you start using this medicine because it
More information1. What Naropin is and what it is used for
Package leaflet: Information for the user Naropin 2 mg/ml, 7.5 mg/ml, 10 mg/ml solution for injection Naropin 2 mg/ml solution for infusion Ropivacaine hydrochloride Read all of this leaflet carefully
More informationMEDICATION GUIDE Morphine Sulfate (mor-pheen) (CII) Oral Solution
MEDICATION GUIDE Morphine Sulfate (mor-pheen) (CII) Oral Solution IMPORTANT: Keep Morphine Sulfate Oral Solution in a safe place away from children. Accidental use by a child is a medical emergency and
More informationPACKAGE LEAFLET: INFORMATION FOR THE USER. MEPHENON 10mg/1ml, solution for injection MEPHENON 5mg, tablets. Methadone hydrochloride
PACKAGE LEAFLET: INFORMATION FOR THE USER MEPHENON 10mg/1ml, solution for injection MEPHENON 5mg, tablets Methadone hydrochloride Read all of this leaflet carefully before you start using this medicine
More informationPACKAGE LEAFLET: INFORMATION FOR THE USER. Active substance: enoximone
PACKAGE LEAFLET 1 PACKAGE LEAFLET: INFORMATION FOR THE USER Perfan Injection 100 mg/20 ml Concentrate for Solution for Injection Active substance: enoximone Read all of this leaflet carefully before you
More informationWhat is the most important information I should know about Morphine Sulfate Oral Solution?
Medication Guide MORPHINE SULFATE (mor-pheen) (CII) Oral Solution IMPORTANT: Keep Morphine Sulfate Oral Solution in a safe place away from children. Accidental use by a child is a medical emergency and
More informationPackage leaflet: Information for the user. Cetiristad 10 mg film-coated tablets Cetirizine dihydrochloride
Package leaflet: Information for the user Cetiristad 10 mg film-coated tablets Cetirizine dihydrochloride Read all of this leaflet carefully before you start taking this medicine because it contains important
More informationPackage leaflet: Information for the user. Atropin Stragen 0.1 mg/ml solution for injection in prefilled syringe.
Package leaflet: Information for the user Atropin Stragen 0.1 mg/ml solution for injection in prefilled syringe Atropine sulphate Read all of this leaflet carefully before you start using this medicine
More informationPackage leaflet: Information for the user. Sevredol 10 mg, 20 mg and 50 mg tablets Morphine sulfate
Package leaflet: Information for the user Sevredol 10 mg, 20 mg and 50 mg tablets Morphine sulfate Read all of this leaflet carefully before you start taking this medicine because it contains important
More informationMEDICATION GUIDE SUBOXONE (Sub OX own) (buprenorphine and naloxone) Sublingual Tablets (CIII)
MEDICATION GUIDE SUBOXONE (Sub OX own) (buprenorphine and naloxone) Sublingual Tablets (CIII) IMPORTANT: Keep SUBOXONE in a secure place away from children. Accidental use by a child is a medical emergency
More informationPackage leaflet: Information for the user
Package leaflet: Information for the user Emerade 150 micrograms solution for injection in pre-filled pen Emerade 300 micrograms solution for injection in pre-filled pen Emerade 500 micrograms solution
More informationNORVASC 5 mg and 10 mg tablets
PACKAGE LEAFLET: INFORMATION FOR THE USER NORVASC 5 mg and 10 mg tablets AMLODIPINE This leaflet is a copy of the Summary of Product Characteristics and Patient Information Leaflet for a medicine, which
More informationPackage leaflet: Information for the user. Omnilax 10 g powder for oral solution, sachet. Macrogol 4000
Package leaflet: Information for the user Omnilax 10 g powder for oral solution, sachet Macrogol 4000 Read all of this leaflet carefully before you start taking this medicine because it contains important
More informationPACKAGE LEAFLET: INFORMATION FOR THE USER Insomniger 10mg and 20mg Tablets (temazepam)
PACKAGE LEAFLET: INFORMATION FOR THE USER Insomniger 10mg and 20mg Tablets (temazepam) Read all of this leaflet carefully before you start taking this medicine. Keep this leaflet. You may need to read
More informationPackage leaflet: Information for the patient. Trasylol 10,000 KIU/ml solution for injection or infusion. Aprotinin
Package leaflet: Information for the patient Trasylol 10,000 KIU/ml solution for injection or infusion Aprotinin Read all of this leaflet carefully before you are given this medicine because it contains
More informationPackage leaflet: Information for the patient
Package leaflet: Information for the patient Triflu Paracetamol, Ascorbic Acid, Pheniramine Maleate 500 mg/200 mg/ 25 mg granules for oral solution in sachet Read all of this leaflet carefully before you
More informationPACKAGE LEAFLET: INFORMATION FOR THE USER ZIRPINE 10mg TABLETS Cetirizine dihydrochloride
PACKAGE LEAFLET: INFORMATION FOR THE USER ZIRPINE 10mg TABLETS Cetirizine dihydrochloride Read all of this leaflet carefully because it contains important information for you. This medicine is available
More informationMEDICATION GUIDE ZUBSOLV (Zub-solve) (buprenorphine and naloxone) Sublingual Tablet (CIII)
MEDICATION GUIDE ZUBSOLV (Zub-solve) (buprenorphine and naloxone) Sublingual Tablet (CIII) IMPORTANT: Keep ZUBSOLV in a secure place away from children. If a child accidentally takes ZUBSOLV, this is a
More informationPACKAGE LEAFLET: INFORMATION FOR THE USER. XIFAXANTA 200 mg film-coated tablets Rifaximin
PACKAGE LEAFLET: INFORMATION FOR THE USER XIFAXANTA 200 mg film-coated tablets Rifaximin Read all of this leaflet carefully before you start taking this medicine because it contains important information
More information1. What Solpadol is and what it is used for
PATIENT INFORMATION LEAFLET SOLPADOL 30mg/500mg CAPLETS Codeine Phosphate and Paracetamol Read all of this leaflet carefully before you start taking this medicine. Keep this leaflet. You may need to read
More informationPackage leaflet: Information for the user. Bupivacaine 0.25% w/v, 0.5% w/v solution for injection Bupivacaine Hydrochloride
Package leaflet: Information for the user Bupivacaine 0.25% w/v, 0.5% w/v solution for injection Bupivacaine Hydrochloride Read all of this leaflet carefully before you start using this medicine because
More informationPACKAGE LEAFLET: INFORMATION FOR THE USER. SALAGEN 5 mg film-coated tablets. Pilocarpine hydrochloride
PACKAGE LEAFLET: INFORMATION FOR THE USER SALAGEN 5 mg film-coated tablets Pilocarpine hydrochloride Read all of this leaflet carefully before you start taking this medicine. Keep this leaflet. You may
More informationPATIENT INFORMATION LEAFLET
PPM Code: E1981 PATIENT INFORMATION LEAFLET SCHEDULING STATUS: S2 PROPRIETARY NAME DOSAGE FORM: film coated tablets Read all of this leaflet carefully because it contains important information for you.
More informationPackage leaflet: Information for the user. Zopiclone Orion 7.5 mg film-coated tablets. zopiclone
Package leaflet: Information for the user Zopiclone Orion 3.75 mg film-coated tablets Zopiclone Orion 7.5 mg film-coated tablets zopiclone Read all of this leaflet carefully before you start taking this
More informationMEDICATION GUIDE CODEINE SULFATE (koh-deen) CII Oral Solution
MEDICATION GUIDE CODEINE SULFATE (koh-deen) CII Oral Solution IMPORTANT: Do not give CODEINE Sulfate Oral Solution to a child to treat pain after tonsillectomy or adenoidectomy surgery. When you take CODEINE
More informationPACKAGE LEAFLET: INFORMATION FOR THE USER. BritLofex Tablets 0.2mg LOFEXIDINE HYDROCHLORIDE
PACKAGE LEAFLET: INFORMATION FOR THE USER BritLofex Tablets 0.2mg LOFEXIDINE HYDROCHLORIDE Read all of this leaflet carefully before you start using this medicine. - Keep this leaflet. You may need to
More informationPackage leaflet: Information for the user Venofer 20 mg iron /ml Solution for injection or concentrate for solution for infusion Iron Sucrose
Package leaflet: Information for the user 20 mg iron /ml Solution for injection or concentrate for solution for infusion Iron Sucrose This medicine is subject to additional monitoring. This will allow
More informationPackage leaflet: Information for the patient. Acetylsalicylic acid Bluefish 75 mg tablets Acetylsalicylic acid Bluefish 160 mg tablets
Package leaflet: Information for the patient Acetylsalicylic acid Bluefish 75 mg tablets Acetylsalicylic acid Bluefish 160 mg tablets Acetylsalicylic acid Read all of this leaflet carefully before you
More informationPATIENT INFORMATION LEAFLET. DOTAREM mg/ml, solution for injection (Gadoteric acid)
PATIENT INFORMATION LEAFLET DOTAREM 279.32 mg/ml, solution for injection (Gadoteric acid) Read all this leaflet carefully before you start using this medicine because it contains important information
More informationPackage leaflet: Information for the patient. Cetirizin Sandoz 10 mg film-coated tablets. cetirizine dihydrochloride
Package leaflet: Information for the patient Cetirizin Sandoz 10 mg film-coated tablets cetirizine dihydrochloride [For medicine available only on prescription:] Read all of this leaflet carefully before
More informationPACKAGE LEAFLET: INFORMATION FOR THE USER. Zoledronic Acid IBIGEN 4 mg powder and solvent for solution for infusion Zoledronic acid
PACKAGE LEAFLET: INFORMATION FOR THE USER Zoledronic Acid IBIGEN 4 mg powder and solvent for solution for infusion Zoledronic acid Read all of this leaflet carefully before you are given Zoledronic Acid
More informationPackage leaflet: Information for the user. Melatonin Pharma Nord 3 mg, film-coated tablets melatonin
Package leaflet: Information for the user Melatonin Pharma Nord 3 mg, film-coated tablets Read all of this leaflet carefully before you start taking this medicine because it contains important information
More informationTOULARYNX DEXTROMETHORPHAN FORTE 3 mg/ml, syrup Dextromethorphan HBr monohydrate
TOULARYNX DEXTROMETHORPHAN FORTE 3 mg/ml, syrup Dextromethorphan HBr monohydrate Read all of this leaflet carefully before you start taking this medicine because it contains important information for you.
More informationSUBOXONE (buprenorphine and naloxone) sublingual film (CIII) IMPORTANT SAFETY INFORMATION
SUBOXONE (buprenorphine and naloxone) sublingual film (CIII) IMPORTANT SAFETY INFORMATION What is the most important information I should know about SUBOXONE Film? Keep SUBOXONE Film in a secure place
More informationPACKAGE LEAFLET: INFORMATION FOR THE USER. Cisatracurium 2 mg/ml Solution for Injection/Infusion Cisatracurium 5 mg/ml Solution for Injection/Infusion
PACKAGE LEAFLET: INFORMATION FOR THE USER Cisatracurium 2 mg/ml Solution for Injection/Infusion Cisatracurium 5 mg/ml Solution for Injection/Infusion Cisatracurium Read all of this leaflet carefully before
More informationPACKAGE LEAFLET. Page 1 of 6
PACKAGE LEAFLET Page 1 of 6 Package leaflet: Information for the patient Procyclidine Hydrochloride 5 mg Tablets (procyclidine hydrochloride) Read all of this leaflet carefully before you start taking
More informationPACKAGE LEAFLET: INFORMATION FOR THE USER Paracodin 0.20% w/w Syrup (dihydrocodeine hydrogen tartrate)
PACKAGE LEAFLET: INFORMATION FOR THE USER Paracodin 0.20% w/w Syrup (dihydrocodeine hydrogen tartrate) Read all of this leaflet carefully before you start taking this medicine because it contains important
More informationMaxilief Effervescent Tablets
Package Leaflet: Information for the user Maxilief Effervescent Tablets Paracetamol Codeine Phosphate Hemihydrate Caffeine 500mg 8mg 30mg Read all of this leaflet carefully before you start taking this
More informationPackage leaflet: Information for the patient. Lacosamide G.L. 10 mg/ml solution for infusion lacosamide
Package leaflet: Information for the patient Lacosamide G.L. 10 mg/ml solution for infusion lacosamide Read all of this leaflet carefully before you start using this medicine because it contains important
More informationPackage leaflet: Information for the patient. Bumetanide 1 mg and 5 mg Tablets (bumetanide)
Package leaflet: Information for the patient Bumetanide 1 mg and 5 mg Tablets (bumetanide) Read all of this leaflet carefully before you start taking this medicine because it contains important information
More informationMIDAZOLAM APOTEX Solution for Injection Contains the active ingredient midazolam
MIDAZOLAM APOTEX Solution for Injection Contains the active ingredient midazolam Consumer Medicine Information For a copy of a large print leaflet, Ph: 1800 195 055 What is in this leaflet Read this leaflet
More informationPackage leaflet: Information for the user. <PRODUCT NAME> 10 g powder for oral solution in sachet Macrogol 4000
Package leaflet: Information for the user 10 g powder for oral solution in sachet Macrogol 4000
More informationPACKAGE LEAFLET: INFORMATION FOR THE PATIENT. ILAXTEN 20 MG TABLETS bilastine
PACKAGE LEAFLET: INFORMATION FOR THE PATIENT ILAXTEN 20 MG TABLETS bilastine Read all of this leaflet carefully before you start taking this medicine because it contains important information for you.
More informationPackage leaflet: Information for the user. Paralink 10 mg/ml Solution for Infusion Paracetamol
Package leaflet: Information for the user Paralink 10 mg/ml Solution for Infusion Paracetamol Read all of this leaflet carefully before you are given this medicine because it contains important information
More informationPackage leaflet: Information for the user. Compound Macrogol Oral Powder Sugar Free
Package leaflet: Information for the user Compound Macrogol Oral Powder Sugar Free Read all of this leaflet carefully before you start taking this medicine because it contains important information for
More informationPackage Leaflet: Information for the user Kemadrin 5 mg Tablets Procyclidine hydrochloride
Package Leaflet: Information for the user Kemadrin 5 mg Tablets Procyclidine hydrochloride Read all of this leaflet carefully before you start taking this medicine because it contains important information
More informationPackage leaflet: Information for the patient
Page 1 of 5 Package leaflet: Information for the patient Xyzal 5 mg/ml oral drops, solution For adults and children aged 2 years and above Levocetirizine dihydrochloride Read all of this leaflet carefully
More informationPackage leaflet: Information for the patient
Package leaflet: Information for the patient Otezla 10 mg film-coated tablets Otezla 20 mg film-coated tablets Otezla 30 mg film-coated tablets Apremilast This medicine is subject to additional monitoring.
More informationPACKAGE LEAFLET: INFORMATION FOR THE USER. Cisatracurium 2 mg/ml solution for injection/infusion Cisatracurium 5 mg/ml solution for injection/infusion
PACKAGE LEAFLET: INFORMATION FOR THE USER Cisatracurium 2 mg/ml solution for injection/infusion Cisatracurium 5 mg/ml solution for injection/infusion Cisatracurium Read all of this leaflet carefully before
More informationPackage leaflet: Information for the user CODEINE PHOSPHATE TABLETS BP 15mg and 30mg (Codeine Phosphate)
Package leaflet: Information for the user CODEINE PHOSPHATE TABLETS BP 15mg and 30mg (Codeine Phosphate) Read all of this leaflet carefully before you start taking this medicine because it contains important
More informationPackage leaflet: Information for the user. Elaprase 2 mg/ml concentrate for solution for infusion idursulfase
Package leaflet: Information for the user Elaprase 2 mg/ml concentrate for solution for infusion idursulfase This medicine is subject to additional monitoring. This will allow quick identification of new
More informationPACKAGE LEAFLET: INFORMATION FOR THE USER DIAZEPAM 5mg/ 10mgRECTAL SOLUTION
PACKAGE LEAFLET: INFORMATION FOR THE USER DIAZEPAM 5mg/ 10mgRECTAL SOLUTION The name of your medicine is Diazepam rectal solution, which will be referred to as Diazepam or Diazepam solution throughout
More informationDILAUDID and DILAUDID -HP
DILAUDID and DILAUDID -HP 2 mg in 1mL, 10 mg in 1mL and 50 mg in 1mL Injections Hydromorphone hydrochloride (hi-dro-morf-own hi-dro-klor-ide) Consumer Medicine Information What is in this leaflet This
More informationPACKAGE LEAFLET: INFORMATION FOR THE USER. ZADITEN 1 mg/5 ml Oral Solution. Ketotifen (as Ketotifen hydrogen fumarate)
PACKAGE LEAFLET: INFORMATION FOR THE USER ZADITEN 1 mg/5 ml Oral Solution Ketotifen (as Ketotifen hydrogen fumarate) Read all of this leaflet carefully because it contains important information for you.
More informationAVIOMARIN 50 mg tablets
PACKAGE LEAFLET: INFORMATION FOR THE USER AVIOMARIN 50 mg tablets DIMENHYDRINATE This leaflet is a copy of the Summary of Product Characteristics and Patient Information Leaflet for a medicine, which outlines
More informationPackage leaflet: Information for the patient. Vyxeos 44 mg/100 mg powder for concentrate for solution for infusion daunorubicin and cytarabine
Package leaflet: Information for the patient Vyxeos 44 mg/100 mg powder for concentrate for solution for infusion daunorubicin and cytarabine Read all of this leaflet carefully before you start taking
More informationPACKAGE LEAFLET: INFORMATION FOR THE USER. NALOXONE 400 microgram/ml solution for injection or infusion. naloxone hydrochloride
PACKAGE LEAFLET 1 PACKAGE LEAFLET: INFORMATION FOR THE USER NALOXONE 400 microgram/ml solution for injection or infusion naloxone hydrochloride Read all of this leaflet carefully before you start using
More informationPackage Leaflet: Information for the user. Methocarbamol 750mg Film-Coated Tablets
PACKAGE LEAFLET Package Leaflet: Information for the user Methocarbamol 750mg Film-Coated Tablets Read all of this leaflet carefully before you start using this medicine because it contains important information
More information